Structure of Tipranavir
CAS No.: 174484-41-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Tipranavir, a nonpeptidic HIV protease inhibitor (NPPI), inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-PI-resistant HIV-1 isolates.
Synonyms: PNU-140690
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
HIV protease inhibitors restore amphotericin B activity against Candida
Elgammal, Yehia ; Salama, Ehab A ; Seleem, Mohamed N ;
Abstract: Candida auris is an invasive fungal pathogen, representing a global public health threat. It is characterized by high mortality rates among infected individuals, significant antifungal resistance, and a remarkable ability to persist in healthcare environments. While amphotericin B is one of the most powerful antifungal agents for treating Candida infections, approximately 30% of C. auris isolates demonstrate resistance to it. Thus, the development of novel antifungal therapies is vital for tackling its life-threatening infections. In this study, we identified four HIV protease inhibitors (atazanavir, saquinavir, lopinavir and ritonavir) as strong potentiators of amphotericin B against C. auris. A synergistic effect between HIV protease inhibitors and amphotericin B was observed against 15 C. auris isolates with fractional inhibitory concentration index (FICI) ranging from 0.09 to 0.50. Additionally, the combinations between HIV protease inhibitors and amphotericin B showed fungicidal effect, significantly reducing the viable cell count in the time-kill assay within 6 hours. Furthermore, the combinations inhibited biofilm formation of C. auris by 60–75% and exhibited a remarkable suppression of C. albicans hyphae. The in vivo treatment with HIV protease inhibitors combined with amphotericin B resulted in a significant reduction of C. auris colony-forming units (CFU) by 1.7–2.6 Log10 in the C. elegans model. These findings suggest that HIV protease inhibitors, in combination with amphotericin B, are promising candidates for the development of novel antifungal drugs to treat Candida infections.
Show More >
Purchased from AmBeed: 206361-99-1 ; 198904-31-3 ; 174484-41-4 ; 192725-17-0 ; 161814-49-9 ; 150378-17-9
Show More >
Nour M. Alkashef ; Mohamed N. Seleem ;
Abstract: Cryptococcosis is a fungal infection that is becoming increasingly prevalent worldwide, particularly among individuals with compromised immune systems, such as HIV patients. Amphotericin B (AmB) is the first-line treatment mainly combined with flucytosine. The scarcity and the prohibitive cost of this regimen urge the use of fluconazole as an alternative, leading to increased rates of treatment failure and relapses. Therefore, there is a critical need for efficient and cost-effective therapy to enhance the efficacy of AmB. In this study, we evaluated the efficacy of the HIV protease inhibitors (PIs) to synergize the activity of AmB in the treatment of cryptococcosis. Five PIs (ritonavir, atazanavir, saquinavir, lopinavir, and nelfinavir) were found to synergistically potentiate the killing activity of AmB against Cryptococcus strains with ƩFICI ranging between 0.09 and 0.5 against 20 clinical isolates. This synergistic activity was further confirmed in a time-kill assay, where different AmB/PIs combinations exhibited fungicidal activity within 24 hrs. Additionally, PIs in combination with AmB exhibited an extended post-antifungal effect on treated cryptococcal cells for approximately 10 hrs compared to 4 hours with AmB alone. This promising activity against cryptococcal cells did not exhibit increased cytotoxicity towards treated kidney cells, ruling out the risk of drug combination-induced nephrotoxicity. Finally, we evaluated the efficacy of AmB/PIs combinations in the Caenorhabditis elegans model of cryptococcosis, where these combinations significantly reduced the fungal burden of the treated nematodes by approximately 2.44 Log10 CFU (92.4%) compared to the untreated worms and 1.40 Log10 ((39.4%) compared to AmB alone. The cost-effectiveness and accessibility of PIs in resource-limited geographical areas compared to other antifungal agents, such as flucytosine, make them an appealing choice for combination therapy.
Show More >
Purchased from AmBeed: 206361-99-1 ; 159989-64-7 ; 198904-31-3 ; 174484-41-4 ; 192725-17-0 ; 127779-20-8 ; 161814-49-9 ; 155213-67-5 ; 150378-17-9
Show More >
CAS No. : | 174484-41-4 |
Formula : | C31H33F3N2O5S |
M.W : | 602.66 |
SMILES Code : | O=C1C([C@H](CC)C2=CC=CC(NS(C3=CC=C(C(F)(F)F)C=N3)(=O)=O)=C2)=C(O)C[C@](CCC4=CC=CC=C4)(CCC)O1 |
Synonyms : |
PNU-140690
|
MDL No. : | MFCD00949098 |
GHS Pictogram: |
![]() ![]() |
Signal Word: | Danger |
Hazard Statements: | H318-H411 |
Precautionary Statements: | P280-P305+P351+P338+P310 |
Class: | 9 |
UN#: | 3077 |
Packing Group: | Ⅲ |
Description |
Tipranavir (PNU-140690) acts to inhibit the enzymatic function and dimerization of the HIV-1 protease, displaying strong efficacy against HIV-1 strains resistant to multiple protease inhibitors, with IC50 values ranging from 66 to 410 nM[1][2].
|
In Vitro:
Concentration | Treated Time | Description | References |
PBMC | 0.18 μM | 5 days | Evaluate the inhibitory effect of PNU-140690 on HIV-1JR-CSF, IC90 of 0.18 μM | PMC163850 |
H9 cells | 0.16 μM | 5 days | Evaluate the inhibitory effect of PNU-140690 on HIV-1IIIB, IC90 of 0.16 μM | PMC163850 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00197145 | Infection, Human Immunodeficie... More >>ncy Virus I Less << | Phase 3 | Terminated | - | - |
NCT00708162 | HIV Infection | Phase 3 | Completed | - | - |
NCT00042289 | HIV Infections | Phase 4 | Recruiting | September 30, 2019 | - |
NCT03631732 | HIV-1 Infection | Phase 3 | Recruiting | August 2020 | - |
NCT00192660 | HIV-Associated Lipodystrophy S... More >>yndrome Cardiovascular Disease Less << | Phase 4 | Completed | - | Australia, New South Wales ... More >> St. Vincent's Hospital Sydney, New South Wales, Australia, 2010 Less << |
NCT00197145 | - | Terminated | - | - | |
NCT02302547 | HIV | Phase 3 | Completed | - | France ... More >> Unité des Maladies Infectieuses, CHU de CAEN Caen, France, 14033 Service des Maladies Infectieuses, CHR Orléans La Source, ORLEANS CEDEX 2 CHR d'ORLEANS, France, 45067 Service d'Immunologie Clinique centre de Vaccination anti- VIH ANRS Hopital Henri- Mondor Creteil, France, 94010 Service de Médecine Interne et Maladies Infectieuses, Groupe Hospitalier La Rochelle, Cedex 01 La Rochelle, France, 17019 Service de Pneumologie, centre Hospitalier Fontenoy, CH de CHARTRES Le Coudray, France, 28630 CHU de NANCY Nancy, France, 54035 Service des maladies Infectieuses et tropicales, CH GEORGES RENON Niort, France, 79021 Service des Maladies Infectieuses et tropicales, APHP SAINT LOUIS Paris, France, 75475 Hospital Tenon Paris, France, 75970 Centre de diagnostic et thérapeutique, Hopital Hotel Dieu Paris, France, 94010 Consultation Maladies Infectieuses, Chu de Poitiers, Cedex Poitiers, France, 86021 Maladies Infectieuses, CHU de ROUEN Rouen, France, 76031 Service de Médecine Interne, CH de SAINTONGE- BP 326 Saintes, France, 17108 Médecine Interne, Hôpital FOCH Suresnes, France, 92151 Service Universitaire des Maladies Infectieuses et du Voyageur, CH DRON Tourcoing, France, 59200 Service de Medecine Interne et Maladies Infectieuses, CHRU BRETONNEAU, TOURS CEDEX9 Tours, France, 37044 Less << |
NCT01814722 | - | Terminated(The trial was termi... More >>nated early due to slow recruitment.) Less << | - | - | |
NCT01814722 | - | Terminated(The trial was termi... More >>nated early due to slow recruitment.) Less << | - | - | |
NCT01923311 | Acquired Immune Deficiency Syn... More >>drome (AIDS) HIV Infections Less << | Phase 2 Phase 3 | Terminated | - | United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Italy Universita degli Studi di Pavia - Fondazione IRCCS Policlinico San Matteo Pavia, Italy, 27100 South Africa Be Part Yoluntu Centre Cape Town, South Africa, 7646 Rahima Moosa Mother and Child Hopsital Johannesburg, South Africa, 2112 Spain Hospital Universitario De Getafe Getafe, Madrid, Spain, 28095 Hospital 12 de Octubre Madrid, Spain, 28041 Thailand Thai Red Cross AIDS Research Centre (HIV-NAT) Bangkok, Thailand, 10330 Siriraj Hospital Bangkok, Thailand, 10700 Uganda Joint Clinical Research Centre Kampala, Uganda Less << |
NCT01923311 | - | Terminated | - | - | |
NCT00708162 | - | Completed | - | - | |
NCT00966329 | HIV HIV Infec... More >>tions Less << | Phase 4 | Completed | - | Spain ... More >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Lluita contra la Sida Foundation, HIV Unit, Irsi Caixa Foundation Badalona, Barcelona, Spain, 08916 Lluita contra la Sida Foundation, HIV Unit Badalona, Barcelona, Spain, 08916 Less << |
NCT01232361 | - | Completed | - | United States, Alabama ... More >> Univ. of Alabama Birmingham NICHD CRS (5096) Birmingham, Alabama, United States, 35294 United States, California Miller Children's Hospital Long Beach (5093) Long Beach, California, United States, 90806 Usc La Nichd Crs (5048) Los Angeles, California, United States, 90033 UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) Los Angeles, California, United States, 90095 Univ of California, San Diego (UCSD) (4601) San Diego, California, United States, 92103 United States, Colorado Childrens Hospital (U. Colorado, Denver) NICHD CRS (5052) Denver, Colorado, United States, 80218-1088 United States, District of Columbia Children's National Med. Ctr. Washington DC NICHD CRS (5015) Washington, District of Columbia, United States, 20010 United States, Florida South Florida CDC Ft Lauderdale NICHD CRS (5055) Ft Lauderdal, Florida, United States, 33316 Univ of Miami Pediatric/Perinatal HIV/AIDS (4201) Miami, Florida, United States, 33136 United States, Illinois Chicago Children's CRS (4001) Chicago, Illinois, United States, 60611 Rush University Cook County Hospital NICHD CRS (5083) Chicago, Illinois, United States, 60612 United States, Maryland Johns Hopkins University NICHD CRS (5092) Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston Medical Center Ped. HIV Program NICHD CRS (5011) Boston, Massachusetts, United States, 02118 WNE Maternal Pediatric Adolescent AIDS CRS (7301) Worcester, Massachusetts, United States, 01605 United States, Michigan Wayne State University/Children's Hospital of Michigan NICHD CRS (5041) Detroit, Michigan, United States, 48201 United States, New York Jacobi Med. Ctr. Bronx NICHD CRS (5013) Bronx, New York, United States, 10461 New York University NY (5012) New York, New York, United States, 10016 Columbia IMPAACT Center (4101) New York, New York, United States, 10032 SUNY Stony Brook (5040) Stony Brook, New York, United States, 11794-8111 United States, Tennessee St. Jude Childrens Research Hospital, Memphis (6501) Memphis, Tennessee, United States, 38105-2794 United States, Texas Texas Children's Hosp. CRS (3801) Houston, Texas, United States, 77030 Puerto Rico San Juan City Hosp. PR NICHD CRS (5031) San Juan, Puerto Rico, 00927 Less << | |
NCT00537394 | - | Completed | - | - | |
NCT02486510 | HIV-1 Infection | Early Phase 1 | Terminated(Futility criteria) | - | Spain ... More >> Hospital Universitario Ramon Y Cajal Madrid, Spain, 28034 Hospital Universitario La Paz Madrid, Spain, 28046 Less << |
NCT01276236 | Kaposi's Sarcoma | Not Applicable | Unknown | April 2015 | United States, California ... More >> San Francisco General Hospital, Clinical Trials Unit San Francisco, California, United States, 94110 Less << |
NCT01225406 | - | Completed | - | Thailand ... More >> Chulalongkorn University Bangkok, Thailand, 10330 HIV-NAT Bangkok, Thailand, 10330 Siriraj Hospital, Mahidol University Bangkok, Thailand, 10700 Prapokklao Chantaburi Chantaburi, Thailand, 22000 Nakornping Hospital Chiang Mai, Thailand, 50180 Chiang Rai Regional Hospital Chiang Rai, Thailand, 57000 Khon Kaen University Khon Kaen, Thailand, 40002 Bamrasnaradura Institute Nonthaburi, Thailand, 11000 Surin Hospital Surin, Thailand, 32000 Less << | |
NCT00537394 | HIV Infections | Phase 3 | Completed | - | - |
NCT00735072 | HIV Infection | Phase 4 | Completed | - | United States, California ... More >> University of California San Francisco - San Francisco General Hospital San Francisco, California, United States, 94110 Stanford University Stanford, California, United States, 94305 United States, Illinois Rush University - Stroger Hospital of Cook County Chicago, Illinois, United States, 60612 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Less << |
NCT02105987 | Infection, Human Immunodeficie... More >>ncy Virus Less << | Phase 3 | Completed | - | - |
NCT00624195 | HIV Infections | Phase 2 Phase 3 | Completed | - | United States, California ... More >> HIV Neurobehavioral Research Center, University of California San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94110 United States, Maryland Johns Hopkins University- School of Medicine Baltimore, Maryland, United States, 21287 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York Mount Sinai Medical Center New York, New York, United States, 10024 Less << |
NCT02195466 | Healthy | Phase 1 | Completed | - | - |
NCT02227017 | Healthy | Phase 1 | Completed | - | - |
NCT02105987 | - | Completed | - | - | |
NCT00307502 | HIV Infections | Phase 1 | Completed | - | Spain ... More >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Hospital de Figueres Figueras, Barcelona, Spain, 17600 Fundació Hospital-Asil de Granollers Granollers, Barcelona, Spain, 08400 Hospital de Vic Vic, Barcelona, Spain, 08500 Hospital Universitari Sant Joan de Reus Reus, Tarragona, Spain, 43201 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Less << |
NCT00624195 | - | Completed | - | - | |
NCT00735072 | - | Completed | - | - | |
NCT00615563 | - | Completed | - | - | |
NCT00447902 | HIV Infections | Phase 3 | Terminated | - | United States, California ... More >> 1182.99.32 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States United States, Florida 1182.99.31 Boehringer Ingelheim Investigational Site Fort Lauderdale, Florida, United States United States, Rhode Island 1182.99.12 Boehringer Ingelheim Investigational Site Providence, Rhode Island, United States United States, Texas 1182.99.1 Boehringer Ingelheim Investigational Site Austin, Texas, United States 1182.99.4 Boehringer Ingelheim Investigational Site Houston, Texas, United States Argentina 1182.99.54001 Capital Federal, Argentina Brazil 1182.99.55002 Hospital DIA Sacomã - São Paulo, Brazil 1182.99.55004 Unidade de Referência em doenças Infecciosas Preveníveis Santo André, Brazil 1182.99.55001 Universidade Federal de Sao Paulo Sao Paulo, Brazil 1182.99.55003 Centro de Referência e Treinamento - DST/AIDS Vila Mariana - Sao Paulo, Brazil France 1182.99.3301A Boehringer Ingelheim Investigational Site Garches, France 1182.99.3306G Boehringer Ingelheim Investigational Site Nantes, France 1182.99.3306K Boehringer Ingelheim Investigational Site Nantes, France 1182.99.3310C Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310D Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310E Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310F Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310G Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310H Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3304A Boehringer Ingelheim Investigational Site Paris, France 1182.99.3304C Boehringer Ingelheim Investigational Site Paris, France 1182.99.3302A Boehringer Ingelheim Investigational Site Perpignan, France Germany 1182.99.4909 Boehringer Ingelheim Investigational Site Düsseldorf, Germany Italy 1182.99.3912 Boehringer Ingelheim Investigational Site Ancona, Italy 1182.99.3901 Boehringer Ingelheim Investigational Site Milano, Italy 1182.99.3911 Boehringer Ingelheim Investigational Site Milano, Italy 1182.99.3916 Boehringer Ingelheim Investigational Site Milano, Italy 1182.99.3906 Boehringer Ingelheim Investigational Site Pavia, Italy Spain 1182.99.3402 Barcelona, Spain 1182.99.3407 Madrid, Spain Less << |
NCT00447902 | - | Terminated | - | - | |
NCT00294372 | HIV Infections | Phase 2 | Terminated | - | Germany ... More >> Boehringer Ingelheim Investigational Site Berlin, Germany Boehringer Ingelheim Investigational Site Bochum, Germany Boehringer Ingelheim Investigational Site Bonn, Germany Boehringer Ingelheim Investigational Site Erlangen, Germany Boehringer Ingelheim Investigational Site Frankfurt/Main, Germany Boehringer Ingelheim Investigational Site Hamburg, Germany Boehringer Ingelheim Investigational Site Hannover, Germany Boehringer Ingelheim Investigational Site Heidelberg, Germany Boehringer Ingelheim Investigational Site Mainz, Germany Boehringer Ingelheim Investigational Site Munchen, Germany Boehringer Ingelheim Investigational Site Ulm, Germany Less << |
NCT02253849 | Healthy | Phase 1 | Completed | - | - |
NCT02251171 | Healthy | Phase 1 | Completed | - | - |
NCT02229760 | HIV Infections | Phase 1 Phase 2 | Terminated | - | - |
NCT02249442 | Hepatic Insufficiency | Phase 1 | Completed | - | - |
NCT00517192 | - | Terminated | - | - | |
NCT02259855 | Hepatic Insufficiency | Phase 1 | Completed | - | - |
NCT00517192 | HIV Infections | Phase 3 | Terminated | - | - |
NCT00056641 | HIV Infections | Phase 2 | Completed | - | - |
NCT02251132 | Healthy | Phase 1 | Completed | - | - |
NCT02253836 | Healthy | Phase 1 | Completed | - | - |
NCT00440271 | HIV Infections | Phase 3 | Terminated | - | - |
NCT00440271 | - | Terminated | - | - | |
NCT02245438 | Healthy | Phase 1 | Terminated | - | - |
NCT02251873 | Healthy | Phase 1 | Completed | - | - |
NCT02253888 | Healthy | Phase 1 | Completed | - | - |
NCT02253823 | Healthy | Phase 1 | Completed | - | - |
NCT00076999 | HIV Infections | Phase 1 | Completed | - | - |
NCT00097799 | - | - | - | - | |
NCT00144105 | HIV Infections | Phase 2 | Terminated | - | - |
NCT01068925 | HIV Infections | Phase 1 | Completed | - | United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less << |
NCT00976950 | - | Completed | - | Romania ... More >> Boehringer Ingelheim Investigational site 9 Arad, Romania Boehringer Ingelheim Investigational site 13 Bacau, Romania Boehringer Ingelheim Investigational site 17 Brasov, Romania Boehringer Ingelheim Investigational site 18 Brasov, Romania Boehringer Ingelheim Investigational site 19 Brasov, Romania Boehringer Ingelheim Investigational site 1 Bucuresti, Romania Boehringer Ingelheim Investigational site 2 Bucuresti, Romania Boehringer Ingelheim Investigational site 3 Bucuresti, Romania Boehringer Ingelheim Investigational site 4 Bucuresti, Romania Boehringer Ingelheim Investigational site 5 Bucuresti, Romania Boehringer Ingelheim Investigational site 6 Bucuresti, Romania Boehringer Ingelheim Investigational site 7 Bucuresti, Romania Boehringer Ingelheim Investigational site 8 Bucuresti, Romania Boehringer Ingelheim Investigational site 16 Constanta, Romania Boehringer Ingelheim Investigational site 11 Craiova, Romania Boehringer Ingelheim Investigational site 12 Craiova, Romania Boehringer Ingelheim Investigational site 15 Galati, Romania Boehringer Ingelheim Investigational site 20 Tg.Mures, Romania Boehringer Ingelheim Investigational site 10 Timisoara, Romania Boehringer Ingelheim Investigational site 14 Vaslui, Romania Less << | |
NCT02245269 | Healthy | Phase 1 | Completed | - | - |
NCT02243553 | Healthy | Phase 1 | Completed | - | - |
NCT02249416 | Healthy | Phase 1 | Completed | - | - |
NCT00976950 | - | Completed | - | - | |
NCT00805857 | HIV Infections | WITHDRAWN | - | - | |
NCT02239835 | HIV Infections | Phase 2 | Terminated | - | - |
NCT02251769 | Healthy | Phase 1 | Completed | - | - |
NCT02251223 | HIV Infections | Phase 1 Phase 2 | Completed | - | - |
NCT00615290 | - | Completed | - | France ... More >> Boehringer Ingelheim Investigational Site Agen, France Boehringer Ingelheim Investigational Site Aix En Provence, France Boehringer Ingelheim Investigational Site Amiens, France Boehringer Ingelheim Investigational Site Argenteuil, France Boehringer Ingelheim Investigational Site Aulnay Sous Bois, France Boehringer Ingelheim Investigational Site Auxerre, France Boehringer Ingelheim Investigational Site Belfort, France Boehringer Ingelheim Investigational Site Besancon Cedex, France Boehringer Ingelheim Investigational Site Beziers, France Boehringer Ingelheim Investigational Site Bondy, France Boehringer Ingelheim Investigational Site Bordeaux, France Boehringer Ingelheim Investigational Site Briis Sous Forges, France Boehringer Ingelheim Investigational Site Cahors, France Boehringer Ingelheim Investigational Site Cannes, France Boehringer Ingelheim Investigational Site Chartres, France Boehringer Ingelheim Investigational Site Corbeil Essonnes, France Boehringer Ingelheim Investigational Site Creil, France Boehringer Ingelheim Investigational Site Creteil, France Boehringer Ingelheim Investigational Site DAX, France Boehringer Ingelheim Investigational Site Digne, France Boehringer Ingelheim Investigational Site Garches, France Boehringer Ingelheim Investigational Site La Roche Sur Yon, France Boehringer Ingelheim Investigational Site Le Mans, France Boehringer Ingelheim Investigational Site Le Petit Quevilly, France Boehringer Ingelheim Investigational Site Libourne, France Boehringer Ingelheim Investigational Site Lyon, France Boehringer Ingelheim Investigational Site Mantes La Jolie, France Boehringer Ingelheim Investigational Site Marseille, France Boehringer Ingelheim Investigational Site Metz, France Boehringer Ingelheim Investigational Site Mulhouse, France Boehringer Ingelheim Investigational Site Nancy, France Boehringer Ingelheim Investigational Site Nantes, France Boehringer Ingelheim Investigational Site Nevers, France Boehringer Ingelheim Investigational Site Nice, France Boehringer Ingelheim Investigational Site Orleans, France Boehringer Ingelheim Investigational Site Paris, France Boehringer Ingelheim Investigational Site Perigueux, France Boehringer Ingelheim Investigational Site Poitiers, France Boehringer Ingelheim Investigational Site Rouen, France Boehringer Ingelheim Investigational Site Saint Brieuc, France Boehringer Ingelheim Investigational Site Saint Nazaire, France Boehringer Ingelheim Investigational Site Saint-mande, France 1182.127.3301 Boehringer Ingelheim Investigational Site Strasbourg, France Boehringer Ingelheim Investigational Site Strasbourg, France Boehringer Ingelheim Investigational Site Suresnes, France Boehringer Ingelheim Investigational Site Toulouse, France Boehringer Ingelheim Investigational Site Valenciennes, France Boehringer Ingelheim Investigational Site Villeneuve St G, France Less << | |
NCT00615290 | - | Completed | - | - | |
NCT00054717 | HIV Infections | Phase 3 | Completed | - | - |
NCT00933205 | HIV Infections | APPROVED_FOR_MARKETING | - | 1182.16.3202 Boehringer Ingelh... More >>eim Investigational Site, Antwerpen, Belgium|1182.16.3203 Boehringer Ingelheim Investigational Site, Brussel, Belgium|1182.16.3205 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1182.16.3206 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1182.16.3207 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1182.16.3211 Boehringer Ingelheim Investigational Site, Charleroi, Belgium|1182.16.3204 Boehringer Ingelheim Investigational Site, Gent, Belgium|1182.16.3201 Boehringer Ingelheim Investigational Site, Leuven, Belgium|1182.16.3208 Boehringer Ingelheim Investigational Site, Liège, Belgium|1182.16.3212 Boehringer Ingelheim Investigational Site, Liège, Belgium|1182.16.3209 Boehringer Ingelheim Investigational Site, Luxembourg, Belgium|1182.16.5511 Unidade de Pesquisa Clínica (UPC) - AIDS, Campinas - Sp, Brazil|1182.16.5505 Hospital S?o José de Doen?as Infecciosas de Fortaleza, Fortaleza - Ce, Brazil|1182.16.5502 Hospital Nossa Senhora da Concei?, Porto Alegre - Rs, Brazil|1182.16.5504 Hospital das Clínicas de Porto Alegre, Porto Alegre - Rs, Brazil|1182.16.5512 Ambulatório de DST/ AIDS - RS, Porto Alegre - Rs, Brazil|1182.16.5509, Rio de Janeiro - Rj, Brazil|1182.16.5513 Centro de Pesquisa Hospital Evandro Chagras, Rio de Janeiro, Brazil|1182.16.5510, Santos - Sp, Brazil|1182.16.5501 UNIFESP/ Hospital S?o Paulo- Univers. Federal de S?o Paulo, S?o Paulo - Sp, Brazil|1182.16.5506 Casa da AIDS da FMUSP, S?o Paulo - Sp, Brazil|1182.16.5507 Hospital do Servidor Público Estadual de S?o Paulo, S?o Paulo - Sp, Brazil|1182.16.5508, Vila Mariana, Brazil|1182.16.1118, Calgary, Alberta, Canada|1182.16.1104 University of Alberta H-Site, Edmonton, Alberta, Canada|1182.16.1101 St. Paul's Hospital, Vancouver, British Columbia, Canada|1182.16.1111 Downtown Infectious Diseases Clinic, Vancouver, British Columbia, Canada|1182.16.1125 St. Boniface General Hospital, Winnipeg, Manitoba, Canada|1182.16.1131 The Moncton Hospital, Moncton, New Brunswick, Canada|1182.16.1128 Centre for Clinical Research, Halifax, Nova Scotia, Canada|1182.16.1112 McMaster University Medical Centre, Hamilton, Ontario, Canada|1182.16.1126 HIV Care Programme, London, Ontario, Canada|1182.16.1132 Infectious Diseases Consultant, Oakville, Ontario, Canada|1182.16.1102 Canadian Immunodeficiency Research Collaborative Inc., Toronto, Ontario, Canada|1182.16.1107 Sunnybrook & Woman's College Health Science Centre, Toronto, Ontario, Canada|1182.16.1109 Infectious Diseases and HIV, Toronto, Ontario, Canada|1182.16.1110 Toronto East General Hospital, Toronto, Ontario, Canada|1182.16.1114 Toronto General Hospital, Toronto, Ontario, Canada|1182.16.1115, Toronto, Ontario, Canada|1182.16.1124, Toronto, Ontario, Canada|1182.16.1106 Positive Care Clinic, Whitby, Ontario, Canada|1182.16.1120 Metropolitan Campus, Windsor, Ontario, Canada|1182.16.1116 Immune Deficiency Treatment Centre, Monteal, Quebec, Canada|1182.16.1103 Hopital Notre Dame CHUM, Montreal, Quebec, Canada|1182.16.1113 Montreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada|1182.16.1117 Clinique medicale l'Actuel, Montreal, Quebec, Canada|1182.16.1119, Montreal, Quebec, Canada|1182.16.1122 Infectious Diseases, Montreal, Quebec, Canada|1182.16.1130 Clinique Medicale LORI, Montreal, Quebec, Canada|1182.16.4501 Boehringer Ingelheim Investigational Site, Copenhagen, Denmark|1182.16.4502 Boehringer Ingelheim Investigational Site, Hvidovre, Denmark|1182.16.4504 Boehringer Ingelheim Investigational Site, Odense C, Denmark|1182.16.3491 Boehringer Ingelheim Investigational Site, Vic (Barcelona), El Salvador|1182.16.3464 Boehringer Ingelheim Investigational Site, Vizcaya, El Salvador|1182.16.3001 "Andreas Syggros"Hospital of Dermatological & Veneral Diseas, Athens, Greece|1182.16.3002 "Greek Red Cross" Hospital, 3rd Internal Medicine Clinic, Athens, Greece|1182.16.3004 "Attiko" Hospital, 4th Internal Medicine Clinic, UOA, Athens, Greece|1182.16.3005 Laiko Hospital, 2nd District Blood Donation Center & Haemato, Athens, Greece|1182.16.3007 1st Social Insurance Foundation (IKA) Pentelis, Athens, Greece|1182.16.3010 University Hospital of Patras, Patras, Greece|1182.16.3008 "Tzanio" Hospital, Piraeus, Greece|1182.16.3009 AHEPA Hospital, Thessaloniki, Greece|1182.16.3932 Azienda Ospedaliera Umberto I, Ancona, Italy|1182.16.3923 Ospedale Santa Maria Annunziata, Antella (fi), Italy|1182.16.3952 Centro di riferimento oncologico, Aviano - PD, Italy|1182.16.3958 A.O. Ospedale Clinico Consorziale, Bari, Italy|1182.16.3920 Ospedali Riuniti di Bergamo, Bergamo, Italy|1182.16.3946 Ospedale Policlinico S. Orsola Bologna, Bologna, Italy|1182.16.3938 Ospedale Civile Regionale, Bolzano, Italy|1182.16.3901 Università di Brescia, Brescia, Italy|1182.16.3957 A.O. Spedali Civili di Brescia, Brescia, Italy|1182.16.3928 Azienda Ospedaliera, Busto Arsizio (va), Italy|1182.16.3964 Ospedale SS. Trinità, Cagliari, Italy|1182.16.3947 U.O. Malattie Infettive, Catania, Italy|1182.16.3961 Ospedale Pugliese, Catanzaro, Italy|1182.16.3954 Ospedale Civile, Cuggiono-MI, Italy|1182.16.3963 Azienda Ospedaliera Arcispedale S. Anna, Ferrara, Italy|1182.16.3924 Azienda Ospedaliera Careggi, Firenze, Italy|1182.16.3902 Ospedali Riuniti di Foggia, Foggia, Italy|1182.16.3911 U.O. di Malattie Infettive, Foggia, Italy|1182.16.3926 Azienda Ospedaliera, Genova, Italy|1182.16.3927 Azienda Ospedaliera, Genova, Italy|1182.16.3929 Malattie Infettive, Genova, Italy|1182.16.3912 Ospedale "A. Manzoni", Lecco, Italy|1182.16.3925 Azienda Ospedaliera Carlo Poma, Mantova, Italy|1182.16.3951 Ospedale Civile Umberto I, Mestre-VE, Italy|1182.16.3903 Ospedale L. Sacco, Milano, Italy|1182.16.3904 Ospedale Luigi Sacco, Milano, Italy|1182.16.3910 Ospedale Luigi Sacco, Milano, Italy|1182.16.3913 Fondazione Centro S. Raffaele del Monte Tabor, Milano, Italy|1182.16.3953 ospedale Niguarda, Milano, Italy|1182.16.3965 Ospedale Maggiore, Milano, Italy|1182.16.3968 Azienda Ospedaliera Policlinico, Modena, Italy|1182.16.3934 Azienda Ospedaliera D. Cotugno, Napoli, Italy|1182.16.3937 Azienda Ospedaliera D. Cotugno, Napoli, Italy|1182.16.3942 Azienda Ospedaliera di Padova, Padova, Italy|1182.16.3914 Presidio Ospedaliero di Verbania, PALLANZA (Verbania), Italy|1182.16.3948 U.O. Malattie Infettive ed Epatologia, Parma, Italy|1182.16.3909 I.R.C.C.S. Policlinico San Matteo, Pavia, Italy|1182.16.3921 IRCCS Policlinico San Matteo, Pavia, Italy|1182.16.3966 Policlinico Monteluce, Perugia, Italy|1182.16.3955 Ospedale San Salvatore, Pesaro, Italy|1182.16.3967 Ospedale Civile dello Spirito Santo, Pescara, Italy|1182.16.3944 Ospedale Cisanello, Pisa, Italy|1182.16.3931 Ospedale Santa Maria delle Croci, Ravenna, Italy|1182.16.3930 Arcispedale S. Maria Nuova, Reggio Emilia, Italy|1182.16.3905 IRCCS Lazzaro Spallanzani, Roma, Italy|1182.16.3906 IRCCS Lazzaro Spallanzani, Roma, Italy|1182.16.3907 IRCCS Lazzaro Spallanzani, Roma, Italy|1182.16.3908 IRCCS Lazzaro Spallanzani, Roma, Italy|1182.16.3915 Azienda Policlinico Umberto I, Roma, Italy|1182.16.3922 Università "La Sapienza", Roma, Italy|1182.16.3941 Istituto Nazionale per le Malattie Infettive, Roma, Italy|1182.16.3960 Università Cattolica del Sacro Cuore, Roma, Italy|1182.16.3945 Istituto Malattie Infettive Università Di Sassari, Sassari, Italy|1182.16.3970 Ospedale San Giuseppe Moscati, Statte (ta), Italy|1182.16.3917 Ospedale Amedeo di Savoia, Torino, Italy|1182.16.3918 Ospedale Amedeo di Savoia, Torino, Italy|1182.16.3919 Ospedale Amedeo di Savoia, Torino, Italy|1182.16.3933 Azienda Ospedaliera Umberto I, Torrette Di Ancona, Italy|1182.16.3939 Ospedale Regionale, Torrette Di Ancona, Italy|1182.16.3940 Presidio Ospedaliero Cà Foncello, Treviso, Italy|1182.16.3943 Policlinico Universitario di Udine, Udine, Italy|1182.16.3916 Ospedale di Circolo e Fondazione Macchi, Varese, Italy|1182.16.3950 Ospedale SS. Giovanni e Paolo, Venezia, Italy|1182.16.3949 Policlinico Rossi "Borgo Roma", Verona, Italy|1182.16.3959 Ospedale Civile di Vicenza - USSL 6, Vicenza, Italy|1182.16.3503 Centro Hospitalar de Lisboa, Lisboa, Portugal|1182.16.3502 Hospital S?o Francisco Xavier, Lisbon, Portugal|1182.16.3505 Hospital Santa Maria, Lisbon, Portugal|1182.16.3501 Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal|1182.16.3504 Hospital Joaquim Urbano, Porto, Portugal|1182.16.3419 Boehringer Ingelheim Investigational Site, A Coru?a, Spain|1182.16.3412 Boehringer Ingelheim Investigational Site, Alcalá de Henares (Madrid), Spain|1182.16.3432 Boehringer Ingelheim Investigational Site, Alicante, Spain|1182.16.3484 Boehringer Ingelheim Investigational Site, Almeria, Spain|1182.16.3487 Boehringer Ingelheim Investigational Site, Arrecife (Lanzarote), Spain|1182.16.3474 Boehringer Ingelheim Investigational Site, Aviles (Asturias), Spain|1182.16.3440, Badalona, Spain|1182.16.3454 Boehringer Ingelheim Investigational Site, Baracaldo (Vizcaya), Spain|1182.16.3438 Boehringer Ingelheim Investigational Site, Barcelona, Spain|1182.16.3442 Boehringer Ingelheim Investigational Site, Barcelona, Spain|1182.16.3448 Boehringer Ingelheim Investigational Site, Barcelona, Spain|1182.16.3449 Boehringer Ingelheim Investigational Site, Barcelona, Spain|1182.16.3463 Boehringer Ingelheim Investigational Site, Bilbao, Spain|1182.16.3476 Boehringer Ingelheim Investigational Site, Cadiz, Spain|1182.16.3430 Boehringer Ingelheim Investigational Site, Cartagena, Spain|1182.16.3462 Boehringer Ingelheim Investigational Site, Castellón, Spain|1182.16.3429 Boehringer Ingelheim Investigational Site, Cordoba, Spain|1182.16.3431 Boehringer Ingelheim Investigational Site, El Palmar (MURCIA), Spain|1182.16.3488 Boehringer Ingelheim Investigational Site, Gandia (Valencia), Spain|1182.16.3443 Boehringer Ingelheim Investigational Site, Gerona, Spain|1182.16.3411 Boehringer Ingelheim Investigational Site, Getafe (Madrid), Spain|1182.16.3418 Boehringer Ingelheim Investigational Site, Gijón (ASTURIAS), Spain|1182.16.3427 Boehringer Ingelheim Investigational Site, Granada, Spain|1182.16.3428 Boehringer Ingelheim Investigational Site, Granada, Spain|1182.16.3439 Boehringer Ingelheim Investigational Site, Granollers (Barcelona), Spain|1182.16.3477 Boehringer Ingelheim Investigational Site, Hospitalet de Llobregat (Barcelona), Spain|1182.16.3445 Boehringer Ingelheim Investigational Site, Hospitalet de Llobregat, Spain|1182.16.3480 Boehringer Ingelheim Investigational Site, Huelva, Spain|1182.16.3498 Boehringer Ingelheim Investigational Site, Ibiza, Spain|1182.16.3479 Boehringer Ingelheim Investigational Site, Jaen, Spain|1182.16.3423 Boehringer Ingelheim Investigational Site, Jerez de la Frontera, Spain|1182.16.3436 Boehringer Ingelheim Investigational Site, La Laguna (santa Cruz de Tenerife), Spain|1182.16.3437 Boehringer Ingelheim Investigational Site, Las Palmas de Gran Canarias, Spain|1182.16.3434 Boehringer Ingelheim Investigational Site, Las Palmas de Gran Canaria, Spain|1182.16.3470 Boehringer Ingelheim Investigational Site, Leganés (Madrid), Spain|1182.16.3441 Boehringer Ingelheim Investigational Site, Lleida, Spain|1182.16.3490 Boehringer Ingelheim Investigational Site, Logro?o, Spain|1182.16.3401 Boehringer Ingelheim Investigational Site, Madrid, Spain|1182.16.3402 Boehringer Ingelheim Investigational Site, Madrid, Spain|1182.16.3404 Boehringer Ingelheim Investigational Site, Madrid, Spain|1182.16.3405 Boehringer Ingelheim Investigational Site, Madrid, Spain|1182.16.3406 Boehringer Ingelheim Investigational Site, Madrid, Spain|1182.16.3407 Boehringer Ingelheim Investigational Site, Madrid, Spain|1182.16.3408 Boehringer Ingelheim Investigational Site, Madrid, Spain|1182.16.3409 Boehringer Ingelheim Investigational Site, Madrid, Spain|1182.16.3413 Boehringer Ingelheim Investigational Site, Madrid, Spain|1182.16.3424 Boehringer Ingelheim Investigational Site, Malaga, Spain|1182.16.3494 Boehringer Ingelheim Investigational Site, Manresa (Barcelona), Spain|1182.16.3426 Boehringer Ingelheim Investigational Site, Marbella (Málaga), Spain|1182.16.3493 Boehringer Ingelheim Investigational Site, Mataro, Spain|1182.16.3492, Mataró (Barcelona), Spain|1182.16.3425 Boehringer Ingelheim Investigational Site, Málaga, Spain|1182.16.3410 Boehringer Ingelheim Investigational Site, Móstoles (Madrid), Spain|1182.16.3489 Boehringer Ingelheim Investigational Site, Navarra, Spain|1182.16.3472 Boehringer Ingelheim Investigational Site, Ourense, Spain|1182.16.3417 Boehringer Ingelheim Investigational Site, Oviedo (Asturias), Spain|1182.16.3496 Boehringer Ingelheim Investigational Site, Palma de Mallorca, Spain|1182.16.3450 Boehringer Ingelheim Investigational Site, Plama de Mallorca, Spain|1182.16.3497 Boehringer Ingelheim Investigational Site, Reus (Tarragona), Spain|1182.16.3446 Boehringer Ingelheim Investigational Site, Sabadell (Barcelona), Spain|1182.16.3453 Boehringer Ingelheim Investigational Site, San Sebastian, Spain|1182.16.3435 Boehringer Ingelheim Investigational Site, Santa Cruz de Tenerife, Spain|1182.16.3455 Boehringer Ingelheim Investigational Site, Santander, Spain|1182.16.3415 Boehringer Ingelheim Investigational Site, Santiago de Compostela, Spain|1182.16.3420 Boehringer Ingelheim Investigational Site, Sevilla, Spain|1182.16.3421 Boehringer Ingelheim Investigational Site, Sevilla, Spain|1182.16.3422 Boehringer Ingelheim Investigational Site, Sevilla, Spain|1182.16.3447 Boehringer Ingelheim Investigational Site, Tarragona, Spain|1182.16.3495 Boehringer Ingelheim Investigational Site, Tarragona, Spain|1182.16.3444 Boehringer Ingelheim Investigational Site, Terrassa, Spain|1182.16.3456 Boehringer Ingelheim Investigational Site, Valencia, Spain|1182.16.3457 Boehringer Ingelheim Investigational Site, Valencia, Spain|1182.16.3458 Boehringer Ingelheim Investigational Site, Valencia, Spain|1182.16.3460 Boehringer Ingelheim Investigational Site, Valencia, Spain|1182.16.3461 Boehringer Ingelheim Investigational Site, Valencia, Spain|1182.16.3403 Boehringer Ingelheim Investigational Site, Valladolid, Spain|1182.16.3467 Boehringer Ingelheim Investigational Site, Vigo (Pontevedra), Spain|1182.16.3416 Boehringer Ingelheim Investigational Site, Vigo, Spain|1182.16.3482 Boehringer Ingelheim Investigational Site, Villajoyosa (ALICANTE), Spain|1182.16.3483 Boehringer Ingelheim Investigational Site, Vitoria, Spain|1182.16.3471 Boehringer Ingelheim Investigational Site, Zamora, Spain|1182.16.3451 Boehringer Ingelheim Investigational Site, Zaragoza, Spain|1182.16.3452 Boehringer Ingelheim Investigational Site, zARAGOZA, Spain Less << | |
NCT02251119 | Healthy | Phase 1 | Completed | - | - |
NCT00531206 | - | Completed | - | - | |
NCT02226978 | Healthy | Phase 1 | Completed | - | - |
NCT00054717 | - | Completed | - | - | |
NCT02249130 | HIV Infections | Phase 2 | Completed | - | - |
NCT02253862 | Healthy | Phase 1 | Completed | - | - |
NCT02248883 | Healthy | Phase 1 | Completed | - | - |
NCT00034866 | HIV Infections | Phase 2 | Completed | - | - |
NCT00076999 | - | Completed | - | - | |
NCT00144287 | HIV Infections | Phase 3 | Completed | - | - |
NCT00531206 | - | Completed | - | Germany ... More >> Boehringer Ingelheim Investigational Site Aachen, Germany Boehringer Ingelheim Investigational Site Berlin, Germany Boehringer Ingelheim Investigational Site Bremen, Germany Boehringer Ingelheim Investigational Site Dortmund, Germany Boehringer Ingelheim Investigational Site Düsseldorf, Germany Boehringer Ingelheim Investigational Site Erlangen, Germany Boehringer Ingelheim Investigational Site Frankfurt/Main, Germany Boehringer Ingelheim Investigational Site Freiburg, Germany Boehringer Ingelheim Investigational Site Gießen, Germany Boehringer Ingelheim Investigational Site Halle/Saale, Germany Boehringer Ingelheim Investigational Site Hamburg, Germany Boehringer Ingelheim Investigational Site Hannover, Germany Boehringer Ingelheim Investigational Site Homburg/Saar, Germany Boehringer Ingelheim Investigational Site Karlsruhe, Germany Boehringer Ingelheim Investigational Site Krefeld, Germany Boehringer Ingelheim Investigational Site Köln, Germany Boehringer Ingelheim Investigational Site Leipzig, Germany Boehringer Ingelheim Investigational Site Magdeburg, Germany Boehringer Ingelheim Investigational Site Mainz, Germany Boehringer Ingelheim Investigational Site München, Germany Boehringer Ingelheim Investigational Site Münster, Germany Boehringer Ingelheim Investigational Site Nürnberg, Germany Boehringer Ingelheim Investigational Site Oldenburg, Germany Boehringer Ingelheim Investigational Site Osnabrück, Germany Boehringer Ingelheim Investigational Site Saarbrücken, Germany Boehringer Ingelheim Investigational Site Stuttgart, Germany Boehringer Ingelheim Investigational Site Wuppertal, Germany Less << | |
NCT02238314 | HIV Infections | Phase 2 | Completed | - | - |
NCT00144170 | HIV Infections | Phase 3 | Completed | - | - |
NCT00530920 | HIV Infections | Phase 2 | Completed | - | Germany ... More >> 1182.107.49002 Boehringer Ingelheim Investigational Site Berlin, Germany 1182.107.49004 Boehringer Ingelheim Investigational Site Berlin, Germany 1182.107.49003 Boehringer Ingelheim Investigational Site Frankfurt/Main, Germany 1182.107.49001 Boehringer Ingelheim Investigational Site München, Germany Italy 1182.107.39001 Boehringer Ingelheim Investigational Site Antella (fi), Italy 1182.107.39009 Boehringer Ingelheim Investigational Site Bari, Italy 1182.107.39007 Boehringer Ingelheim Investigational Site Ferrara, Italy 1182.107.39011 Boehringer Ingelheim Investigational Site Palermo, Italy Spain 1182.107.34001 Boehringer Ingelheim Investigational Site Barcelona, Spain 1182.107.34002 Boehringer Ingelheim Investigational Site Barcelona, Spain 1182.107.34003 Boehringer Ingelheim Investigational Site L'Hospitalet de Llobregat, Spain 1182.107.34004 Boehringer Ingelheim Investigational Site Madrid, Spain Less << |
NCT00352066 | HIV Infection | Phase 1 | Completed | - | United States, Michigan ... More >> Jasper Clinic Inc Kalamazoo, Michigan, United States, 49007 Less << |
NCT00144170 | - | Completed | - | - | |
NCT02251145 | Healthy | Phase 1 | Completed | - | - |
NCT02245451 | Healthy | Phase 1 | Completed | - | - |
NCT00275444 | HIV Infections | PHASE2 | COMPLETED | - | Boehringer Ingelheim Investiga... More >>tional Site, Phoenix, Arizona, United States|Boehringer Ingelheim Investigational Site, Fountain Valley, California, United States|Living Hope Clinical Trials, Inc., Long Beach, California, United States|Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|David Geffen School of Medicine at UCLA, Los Angeles, California, United States|Vincent Lombardi Cancer Center, Washington, District of Columbia, United States|Therafirst Medical Center, Fort Lauderdale, Florida, United States|1501 N.W. 9th Ave, Miami, Florida, United States|Boehringer Ingelheim Investigational Site, Orlando, Florida, United States|Boehringer Ingelheim Investigational Site, South Miami, Florida, United States|Hillsborough County Health Dept., Tampa, Florida, United States|Boehringer Ingelheim Investigational Site, Vero Beach, Florida, United States|Boehringer Ingelheim Investigational Site, Atlanta, Georgia, United States|Atlanta VA Medical Center, Decatur, Georgia, United States|Mercer University School of Medicine, Macon, Georgia, United States|CORE Center, Chicago, Illinois, United States|Rush-Presbytarian-St Luke's Medical Center, Chicago, Illinois, United States|University of Louisville, Louisville, Kentucky, United States|HIV Outpatient Program (H.O.P), New Orleans, Louisiana, United States|John's Hopkins University, Baltimore, Maryland, United States|Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States|Community Research Initiative of New England, Springfield, Massachusetts, United States|University of Michigan Health System, Ann Arbor, Michigan, United States|Boehringer Ingelheim Investigational Site, Kansas City, Missouri, United States|Washington University, Saint Louis, Missouri, United States|Boehringer Ingelheim Investigational Site, Las Vegas, Nevada, United States|ID Care, Hillsborough, New Jersey, United States|Boehringer Ingelheim Investigational Site, Santa Fe, New Mexico, United States|Albany Medical College, Albany, New York, United States|University of New York at Stony Brook, Stony Brook, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Boehringer Ingelheim Investigational Site, Huntersville, North Carolina, United States|Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States|Ohio State University Medical Center, Columbus, Ohio, United States|Boehringer Ingelheim Investigational Site, Oklahoma City, Oklahoma, United States|Boehringer Ingelheim Investigational Site, Columbia, South Carolina, United States|Boehringer Ingelheim Investigational Site, Houston, Texas, United States|Boehringer Ingelheim Investigational Site, Annandale, Virginia, United States|Boehringer Ingelheim Investigational Site, Darlinghurst, New South Wales, Australia|St. Vincent's Hospital, Darlinghurst, New South Wales, Australia|Boehringer Ingelheim Investigational Site, Ottawa, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Montreal Chest Institute - McGill University Health Centre, Montreal, Quebec, Canada|H?pital de Bicêtre, Le Kremlin Bicêtre cedex, France|H?pital de Chauliac, Montpellier cedex 5, France|H?pital H?tel Dieu, Nantes cedex 1, France|H?pital Saint Louis, Paris cedex 10, France|H?pital de la pitié Salpetrière, Paris cedex 13, France|H?pital Bichat Claude Bernard, Paris cedex 18, France|Epimed GmbH, Berlin, Germany|Klinikum der J.-W.-Goethe-Universit?t, Frankfurt/Main, Germany|Klinik I für Innere Medizin der, K?ln, Germany|Medizinische Poliklinik, München, Germany|Fondazione Centro S. Raffaele del Monte Tabor, Milano, Italy|IRCCS Policlinico San Matteo, Pavia, Italy|Academisch Medisch Centrum, Amsterdam, Netherlands|Erasmus Medical Centre, Rotterdam, Netherlands|Hospital Clínico y Provincial de Barcelona - HIV, Barcelona, Spain|Boehringer Ingelheim Investigational Site, Madrid, Spain|Hospital La Paz., Madrid, Spain|Hospital Ramón y Cajal., Madrid, Spain|4th Floor Research Office (St Stephens Centre), London, United Kingdom Less << |
NCT00146328 | HIV Infections | PHASE2|PHASE3 | COMPLETED | - | 1182.17.39 MDS Pharma Services... More >>, Phoenix, Arizona, United States|1182.17.75 Boehringer Ingelheim Investigational Site, Phoenix, Arizona, United States|1182.17.89 Boehringer Ingelheim Investigational Site, Berkeley, California, United States|1182.17.60 Boehringer Ingelheim Investigational Site, Fountain Valley, California, United States|1182.17.106 Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|1182.17.15 Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|1182.17.40 Tower ID Medical, Los Angeles, California, United States|1182.17.46 Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|1182.17.47 University of Southern California, Los Angeles, California, United States|1182.17.73 Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|1182.17.114 Boehringer Ingelheim Investigational Site, San Diego, California, United States|1182.17.128 Boehringer Ingelheim Investigational Site, San Diego, California, United States|1182.17.37 Boehringer Ingelheim Investigational Site, San Francisco, California, United States|1182.17.58 Boehringer Ingelheim Investigational Site, San Francisco, California, United States|1182.17.96 Boehringer Ingelheim Investigational Site, San Francisco, California, United States|1182.17.87 Boehringer Ingelheim Investigational Site, Norwalk, Connecticut, United States|1182.17.112 Boehringer Ingelheim Investigational Site, Washington, District of Columbia, United States|1182.17.43 Boehringer Ingelheim Investigational Site, Washington, District of Columbia, United States|1182.17.65 Boehringer Ingelheim Investigational Site, Washington, District of Columbia, United States|1182.17.126 Boehringer Ingelheim Investigational Site, Fort Lauderdale, Florida, United States|1182.17.8 Boehringer Ingelheim Investigational Site, Fort Myers, Florida, United States|1182.17.131 Boehringer Ingelheim Investigational Site, Miami, Florida, United States|1182.17.22 Boehringer Ingelheim Investigational Site, Miami, Florida, United States|1182.17.64 Boehringer Ingelheim Investigational Site, Orlando, Florida, United States|1182.17.129 Boehringer Ingelheim Investigational Site, Sarasota, Florida, United States|1182.17.51 Boehringer Ingelheim Investigational Site, South Miami, Florida, United States|1182.17.125 Boehringer Ingelheim Investigational Site, Tampa, Florida, United States|1182.17.132 Boehringer Ingelheim Investigational Site, Tampa, Florida, United States|1182.17.76 Boehringer Ingelheim Investigational Site, Tampa, Florida, United States|1182.17.52 Boehringer Ingelheim Investigational Site, Vero Beach, Florida, United States|1182.17.77 Boehringer Ingelheim Investigational Site, Atlanta, Georgia, United States|1182.17.69 Boehringer Ingelheim Investigational Site, Macon, Georgia, United States|1182.17.136 Boehringer Ingelheim Investigational Site, Chicago, Illinois, United States|1182.17.70 Boehringer Ingelheim Investigational Site, Chicago, Illinois, United States|1182.17.36 Boehringer Ingelheim Investigational Site, Evanston, Illinois, United States|1182.17.1 Boehringer Ingelheim Investigational Site, Indianapolis, Indiana, United States|1182.17.32 University of Kansas School of Medicine - Wichita, Wichita, Kansas, United States|1182.17.102 Boehringer Ingelheim Investigational Site, Lexington, Kentucky, United States|1182.17.21 Boehringer Ingelheim Investigational Site, Louisville, Kentucky, United States|1182.17.30 Boehringer Ingelheim Investigational Site, Portland, Maine, United States|1182.17.67 Boehringer Ingelheim Investigational Site, Baltimore, Maryland, United States|1182.17.86 Boehringer Ingelheim Investigational Site, Bethesda, Maryland, United States|1182.17.111 Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States|1182.17.63 Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States|1182.17.74 Boehringer Ingelheim Investigational Site, Springfield, Massachusetts, United States|1182.17.4 Boehringer Ingelheim Investigational Site, Ann Arbor, Michigan, United States|1182.17.115 Boehringer Ingelheim Investigational Site, Detroit, Michigan, United States|1182.17.6 Boehringer Ingelheim Investigational Site, Detroit, Michigan, United States|1182.17.62 Boehringer Ingelheim Investigational Site, Kansas City, Missouri, United States|1182.17.59 Boehringer Ingelheim Investigational Site, Las Vegas, Nevada, United States|1182.17.118 Early Intervention Program (EIP) Clinic, Camden, New Jersey, United States|1182.17.93 Boehringer Ingelheim Investigational Site, East Orange, New Jersey, United States|1182.17.24 Hackensack University Medical Center, Hackensack, New Jersey, United States|1182.17.34 ID Care, Inc., Hillsborough, New Jersey, United States|1182.17.50 Boehringer Ingelheim Investigational Site, Santa Fe, New Mexico, United States|1182.17.79 Boehringer Ingelheim Investigational Site, Albany, New York, United States|1182.17.103 Boehringer Ingelheim Investigational Site, Mount Vernon, New York, United States|1182.17.105 Pollari Medical Group, New York, New York, United States|1182.17.130 Boehringer Ingelheim Investigational Site, New York, New York, United States|1182.17.3 Division of Infectious Diseases, New York, New York, United States|1182.17.42 Beth Israel Medical Center, New York, New York, United States|1182.17.5 Boehringer Ingelheim Investigational Site, New York, New York, United States|1182.17.7 Boehringer Ingelheim Investigational Site, New York, New York, United States|1182.17.94 Boehringer Ingelheim Investigational Site, New York, New York, United States|1182.17.135 Boehringer Ingelheim Investigational Site, Rochester, New York, United States|1182.17.31 Boehringer Ingelheim Investigational Site, Stony Brook, New York, United States|1182.17.53 Boehringer Ingelheim Investigational Site, Durham, North Carolina, United States|1182.17.54 Boehringer Ingelheim Investigational Site, Huntersville, North Carolina, United States|1182.17.134 Summa Health System, Akron, Ohio, United States|1182.17.95 Boehringer Ingelheim Investigational Site, Cincinnati, Ohio, United States|1182.17.26 Boehringer Ingelheim Investigational Site, Columbus, Ohio, United States|1182.17.9 Boehringer Ingelheim Investigational Site, Oklahoma City, Oklahoma, United States|1182.17.110 Boehringer Ingelheim Investigational Site, Philadelphia, Pennsylvania, United States|1182.17.99 Boehringer Ingelheim Investigational Site, Philadelphia, Pennsylvania, United States|1182.17.23 Boehringer Ingelheim Investigational Site, Columbia, South Carolina, United States|1182.17.11 Boehringer Ingelheim Investigational Site, Memphis, Tennessee, United States|1182.17.18 Vanderbilt AIDS Clinical Trials Center, Nashville, Tennessee, United States|1182.17.116 Boehringer Ingelheim Investigational Site, Dallas, Texas, United States|1182.17.142 Boehringer Ingelheim Investigational Site, Dallas, Texas, United States|1182.17.16 Nelson-Tebedo Clinic, Dallas, Texas, United States|1182.17.122 Boehringer Ingelheim Investigational Site, Houston, Texas, United States|1182.17.68 Boehringer Ingelheim Investigational Site, Houston, Texas, United States|1182.17.97 Boehringer Ingelheim Investigational Site, San Antonio, Texas, United States|1182.17.10 Boehringer Ingelheim Investigational Site, Annandale, Virginia, United States|1182.17.92 Boehringer Ingelheim Investigational Site, Tacoma, Washington, United States|1182.17.100 Boehringer Ingelheim Investigational Site, Milwaukee, Wisconsin, United States|1182.17.5401 Fundacion Huesped, Capital Federal, Argentina|1182.17.5402 Funcei, Capital Federal, Argentina|1182.17.5403 consultorio externo "PETS", Capital Federal, Argentina|1182.17.5404 Infectología, Capital Federal, Argentina|1182.17.5405 Dpto. de Enfermedades infecciosas (Pabellón 22), Capital Federal, Argentina|1182.17.5406 Pabellón de Clínicas 2° Piso, Capital Federal, Argentina|1182.17.401 St. Vincent's Hospital, Darlinghurst, New South Wales, Australia|1182.17.402 Taylor Square Private Clinic, Darlinghurst, New South Wales, Australia|1182.17.405 AIDS Research Initiative, DarlingHurst, New South Wales, Australia|1182.17.407 Holdsworth House General Practice, Darlinghurst, New South Wales, Australia|1182.17.408 407 Doctors Pty Ltd., Darlinghurst, New South Wales, Australia|1182.17.403 Albion Street Clinic, Surry Hills, New South Wales, Australia|1182.17.404 Alfred Hospital, Melbourne, Victoria, Australia|1182.17.4301 Boehringer Ingelheim Investigational Site, Wien, Austria|1182.17.3209 Instituut Tropische Geneeskunde, Antwerpen, Belgium|1182.17.3201 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1182.17.3202 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1182.17.3207 Boehringer Ingelheim Investigational Site, Gent, Belgium|1182.17.3210 Centre Hospitalier de Luxembourg, Luxembourg, Belgium|1182.17.5511 Universidade Federal da Bahia, Canela - Salvador - BA, Brazil|1182.17.5508 I.I. Emilio Ribas, Cerqueira César, S?o Paulo - SP, Brazil|1182.17.5509 (Unidade de Testes Terapêuticos), Cidade Nova - Rio de Janeiro - RJ, Brazil|1182.17.5502 Farmácia do Instituto de Pesquisa Evandro Chagas, Manguinhos - Rio de Janeiro - RJ, Brazil|1182.17.5505 Instituto A-Z de Pesquisa e Ensino da PUC, Mercês - Curitiba - PR, Brazil|1182.17.5507 Hospital Geral de Nova Igua?u - Ministério da Saúde, Nova Igua?u - Rio de Janeiro - RJ, Brazil|1182.17.5501 Hospital Dia, Sacoma - S?o Paulo - SP, Brazil|1182.17.5503 Instituto de Infectologia Emílio Ribas, S?o Paulo - SP, Brazil|1182.17.5504 Enfermaria de MI, S?o Paulo - SP, Brazil|1182.17.5510 Casa de AIDS, S?o Paulo, SP, Brazil|1182.17.5506 Centro de Referência e Treinamento - DST/AIDS, Vila Mariana, Sao Paulo - SP, Brazil|1182.17.902 Downtown Infectious Diseases Clinic, Vancouver, British Columbia, Canada|1182.17.913 McMaster University Medical Centre, Hamilton, Ontario, Canada|1182.17.901 Division of Infectious Diseases, Ottawa, Ontario, Canada|1182.17.905 Canadian Immunodeficiency Research Collaborative Inc., Toronto, Ontario, Canada|1182.17.906 Infectious Diseases & HIV - St. Michael's Hospital, Toronto, Ontario, Canada|1182.17.907 University Health Network - Toronto General Hospital, Toronto, Ontario, Canada|1182.17.910 Sunnybrook & Women's College Health Science Centre, Toronto, Ontario, Canada|1182.17.914 Montreal General Hospital - McGill University Health Centre, Monteal, Quebec, Canada|1182.17.903 Montreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada|1182.17.904 Clinique Medicale Du Quartier Latin, Montreal, Quebec, Canada|1182.17.915 Clinique medicale l'Actuel, Montreal, Quebec, Canada|1182.17.4505 Boehringer Ingelheim Investigational Site, Aarhus N, Denmark|1182.17.4501 Boehringer Ingelheim Investigational Site, Copenhagen ?, Denmark|1182.17.4502 Boehringer Ingelheim Investigational Site, Hvidovre, Denmark|1182.17.4504 Boehringer Ingelheim Investigational Site, Odense, Denmark|1182.17.33011 H?pital Pellegrin, Bordeaux cedex, France|1182.17.33019 H?pital Saint André, Bordeaux cedex, France|1182.17.33020 H?pital C?te de Nacre, Caen cedex 5, France|1182.17.33007 H?pital Antoine Beclere, Clamart, France|1182.17.33008 H?pital de l'H?tel Dieu, Lyon cedex 2, France|1182.17.33023 H?pital Edouard Herriot, Lyon cedex 3, France|1182.17.33012 H?pital de la Conception, Marseille cedex 5, France|1182.17.33013 H?pital Sainte Marguerite, Marseille cedex 9, France|1182.17.00336 H?pital H?tel Dieu, Nantes cedex 1, France|1182.17.33010 H?pital de l'Archet, Nice cedex 3, France|1182.17.33024 Groupe Hospitalier Cochin, Paris cedex 14, France|1182.17.33022 H?pital Européen Georges Pompidou, Paris cedex 15, France|1182.17.00335 H?pital Bichat Claude Bernard, Paris cedex 18, France|1182.17.00331 H?pital Tenon, Paris cedex 20, France|1182.17.00333 H?pital Saint Louis, Paris, France|1182.17.00334 H?pital de la Pitié Salpêtrière, Paris, France|1182.17.33014 H?pital Saint Antoine, Paris, France|1182.17.33018 H?pital de Pontchaillou, Rennes cedex 9, France|1182.17.33016 H?pital Civil, Strasbourg cedex, France|1182.17.00332 H?pital du Chalucet, Toulon, France|1182.17.33017 H?pital Brabois Adultes, Vandoeuvre les Nancy, France|1182.17.33021 H?pital Paul Brousse, Villejuif cedex, France|1182.17.4911 Arzt für Innere Medizin, Aachen, Germany|1182.17.4901 Epimed GmbH c/o, Berlin, Germany|1182.17.4902 Charite, Campus Virchow-Klinikum, Berlin, Germany|1182.17.4918 Rheinische Friedrich-Wilhelm-Universit?t, Bonn, Germany|1182.17.4906 ID-Ambulanz Klinikum Dortmund, Dortmund, Germany|1182.17.4912 Universit?tsklinikum Düsseldorf, Düsseldorf, Germany|1182.17.4914 Arzt für Innere Medizin, Düsseldorf, Germany|1182.17.4908 Universit?tskliniken Erlangen, Erlangen, Germany|1182.17.4904 Universit?tsklinikum Essen, Essen, Germany|1182.17.4924 Klinikum der J. W.-Goethe-Universit?t, Frankfurt/Main, Germany|1182.17.4930 Universit?tsklinikum Freiburg, Freiburg/Breisgau, Germany|1182.17.4928 Facharzt für Innere Medizin/Rheumatologie, Freiburg, Germany|1182.17.4916 Medizinisches Versorgungszentrum Hamburg, Hamburg, Germany|1182.17.4929 Universit?tsklinikum Eppendorf, Hamburg, Germany|1182.17.4931 IPM Study Center GmbH, Hamburg, Germany|1182.17.4920 Abteilung Klinische Immunologie, Hannover, Germany|1182.17.4909 Universit?tsklinikum Heidelberg, Heidelberg, Germany|1182.17.4905 Universit?tsklinik K?ln, K?ln, Germany|1182.17.4926 Internist, K?ln, Germany|1182.17.4923 Facharzt für Innere Medizin,, Mannheim, Germany|1182.17.4907 Medizinische Poliklinik, München, Germany|1182.17.4910 MUC Research GmbH, München, Germany|1182.17.4915 Klinium Natruper Holz, Osnabrück, Germany|1182.17.4921 Arzt für Allgemeinmedizin, Stuttgart, Germany|1182.17.3001 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3002 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3003 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3004 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3007 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3010 Boehringer Ingelheim Investigational Site, Patras, Greece|1182.17.3009 Boehringer Ingelheim Investigational Site, Thessaloniki, Greece|1182.17.0409 Ospedale Santa Maria Annunziata, Antella (fi), Italy|1182.17.0413 Ospedale di Circolo di Busto, Busto Arsizio (va), Italy|1182.17.0384 Azienda Ospedaliera Arcispedale S. Anna, Ferrara, Italy|1182.17.0397 Ospedale San Martino, Genova, Italy|1182.17.0412 S.C. Malattie Infettive, Genova, Italy|1182.17.0411 Presidio Ospedaliero "A. Manzoni", Lecco, Italy|1182.17.0389 Reparto Malattie Infettive, Macerata, Italy|1182.17.0393 Fondazione Centro S. Raffaele del Monte Tabor, Milano, Italy|1182.17.0386 Policlinico Universitario, Modena, Italy|1182.17.0388 Ospedale A. Cotugno, Napoli, Italy|1182.17.0385 IRCCS Policlinico San Matteo, Pavia, Italy|1182.17.0394 IRCCS Policlinico San Matteo, Pavia, Italy|1182.17.0395 Azienda Policlinico Umberto I, Roma, Italy|1182.17.0419 I Cattedra Malattie Infettive, Roma, Italy|1182.17.0387 Ospedale Amedeo di Savoia, Torino, Italy|1182.17.0398 Ospedale Amedeo di Savoia, Torino, Italy|1182.17.0415 U.O.A. Malattie Infettive B, Torino, Italy|1182.17.5201 Centro Médico La Raza IMSS, Col. La Raza, Mexico, Mexico|1182.17.5203 Hospital Civil Nuevo de Guadalajara, Guadalajara, Mexico|1182.17.5206 Centro Medico San Vicente, Monterrey, N.l., Mexico, Mexico|1182.17.3101 Boehringer Ingelheim Investigational Site, Amsterdam, Netherlands|1182.17.3108 Boehringer Ingelheim Investigational Site, Groningen, Netherlands|1182.17.3105 Boehringer Ingelheim Investigational Site, Nijmegen, Netherlands|1182.17.202 Boehringer Ingelheim Investigational Site, Rotterdam, Netherlands|1182.17.3502 Hospital Condes Castro Guimar?es, Cascais, Portugal|1182.17.705 Hospital Germans Trias i Pujol, Badalona, Spain|1182.17.701 Hospital Clínico y Provincial de Barcelona, Barcelona, Spain|1182.17.703 Hospital 12 de Octubre, Madrid, Spain|1182.17.704 Hospital Ramón y Cajal., Madrid, Spain|1182.17.710 Hospital Gregorio Maranon, Madrid, Spain|1182.17.712 Hospital Clínico San Carlos, Madrid, Spain|1182.17.717 Hospital Clínico Universitario Vírgen de la Victoria, Malaga, Spain|1182.17.713 Hospital Universitario Vírgen del Rocío, Sevilla, Spain|1182.17.714 Hospital General Universitario de Valencia, Valencia, Spain|1182.17.720 Hospital La Fe, Valencia, Spain|1182.17.718 Complejo Hospitalario Xeral - Cíes, Vigo, Spain|1182.17.4101 DIM / Abteilung für Infektiologie, Basel, Switzerland|1182.17.4104 Département de médicine interne Div. Des maladies infectieus, Genève, Switzerland|1182.17.4103 DIM / Abteilung für Infektiologie, St. Gallen, Switzerland|1182.17.4102 Departement für Innere Medizin, Zürich, Switzerland|1182.17.4405 Boehringer Ingelheim Investigational Site, Brighton, United Kingdom|1182.17.4411 Boehringer Ingelheim Investigational Site, Liverpool, United Kingdom|1182.17.4404 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4406 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4408 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4409 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4414 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4418 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4407, Portsmouth, United Kingdom Less << |
NCT00062660 | HIV Infections | APPROVED_FOR_MARKETING | 2025-04-14 | 1182.58.31, Scottsdale, Arizon... More >>a, United States|1182.58.29, Los Angeles, California, United States|1182.58.34 Campus Code 696446, Los Angeles, California, United States|1182.58.42 Synergy Hematology/Oncology, Los Angeles, California, United States|1182.58.43, Los Angeles, California, United States|1182.58.03, San Francisco, California, United States|1182.58.33 Kaiser Permanente Medical Center, Clinical Trials Unit, San Francisco, California, United States|1182.58.37 AIDS Health Care Foundation, Los Angeles, Connecticut, United States|1182.58.41 Circle Medical, LLC, Norwalk, Connecticut, United States|1182.58.28, Washington, District of Columbia, United States|1182.58.38, Miami Beach, Florida, United States|1182.58.40 Drs. Raben and Feldman Research Associates, South Miami, Florida, United States|1182.58.23 Hillsborough County Health Department, Tampa, Florida, United States|1182.58.36 Suite 525, Atlanta, Georgia, United States|1182.58.08, Honolulu, Hawaii, United States|1182.58.22, Chicago, Illinois, United States|1182.58.32, New Orleans, Louisiana, United States|1182.58.15, Boston, Massachusetts, United States|1182.58.19 Henry Ford Hospital, Detroit, Michigan, United States|1182.58.04 Kansas City Free Health Clinic, Kansas City, Missouri, United States|1182.58.25 Wohl Clinic, St. Louis, Missouri, United States|1182.58.02 Wellness Center, Las Vegas, Nevada, United States|1182.58.09 Polari Medical Group, New York, New York, United States|1182.58.30, Chapel Hill, North Carolina, United States|1182.58.06 University of Cincinnati Medical Center, Infectious diseases, Cincinnati, Ohio, United States|1182.58.35, Portland, Oregon, United States|1182.58.14, Philadelphia, Pennsylvania, United States|1182.58.20 University of Pittsburgh, Pittsburgh, Pennsylvania, United States|1182.58.01 Boehringer Ingelheim Investigational Site, Columbia, South Carolina, United States|1182.58.10 Comprehensive Care Center, Nashville, Tennessee, United States|1182.58.18 University of Texas Southwest Medical Center at Dallas, Dallas, Texas, United States|1182.58.07, Houston, Texas, United States|1182.58.039 Olmos Park Medical Associates, San Antonio, Texas, United States|1182.58.11 Swedish Medical Center, Seattle, Washington, United States|1182.58.44 VW Hospital and Clinics, Madison, Wisconsin, United States|1182.58.61005 Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|1182.58.61008 St Vincents Hospital, Darlinghurst, New South Wales, Australia|1182.58.61011 St Vincents Hospital, Darlinghurst, New South Wales, Australia|1182.58.61014 St Vincents Hospital, Darlinghurst, New South Wales, Australia|1182.58.61007 407 Doctors Pty Ltd, Darlinghusrst, New South Wales, Australia|1182.58.61019 407 Bouke Street, Darlinghusrst, New South Wales, Australia|1182.58.61022 Sexual Health Clinic, Kingswood, New South Wales, Australia|1182.58.61012 Bigge Park Centre, Liverpool, New South Wales, Australia|1182.58.61003 The Prince of Wales Hospital, Randwick, New South Wales, Australia|1182.58.61002 Royal North Shore Hospital, St Leonards, New South Wales, Australia|1182.58.61006 Albion Street Clinic, Surry Hills, New South Wales, Australia|1182.58.61025 Immunology Department, Westmead, New South Wales, Australia|1182.58.61010 Biala Building, Brisbane, Queensland, Australia|1182.58.61009 Level 6, Herston, Queensland, Australia|1182.58.61024, Nambour, Queensland, Australia|1182.58.61016 Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|1182.58.61020, Adelaide, South Australia, Australia|1182.58.61015 Flinders Medical Centre, Bedford Park, South Australia, Australia|1182.58.61001 88 Rathdowne Street Carlton, Carlton, Victoria, Australia|1182.58.61018 Melbourne Sexual Health Clinic, Carlton, Victoria, Australia|1182.58.61017 Department of Infectious Diseases, Clayton, Victoria, Australia|1182.58.61013 Melbourne Sexual Health Clinic, Melbourne, Victoria, Australia|1182.58.61023, Melbourne, Victoria, Australia|1182.58.61021, South Yarra, Victoria, Australia|1182.58.61004 Royal Perth Hospital, Perth, Western Australia, Australia|1182.58.3201 Boehringer Ingelheim Investigational Site, Antwerpen, Belgium|1182.58.3202 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1182.58.3203 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1182.58.3204 Boehringer Ingelheim Investigational Site, Liège, Belgium|1182.58.4505 Aarhus Universitetshospital Skejby, Aarhus C, Denmark|1182.58.4501 Rigshospitalet, K?benhavn ?, Denmark|1182.58.4504 Odense Universitetshospital, Odense C, Denmark|1182.58.33029 H?pital Aix, Aix en Provence cedex 1, France|1182.58.33001 H?pital Saint Jacques, Besan?on cedex, France|1182.58.33022 H?pital Avicenne, Bobigny cedex, France|1182.58.33020 H?pital Antoine Beclère, Clamart cedex, France|1182.58.33028 H?pital Louis Mourier, Colombes, France|1182.58.33027 H?pital, Dijon cedex, France|1182.58.33034 H?pital Raymond Poincarré, Garches, France|1182.58.33006 H?pital Bicêtre, Le Kremlin Bicêtre cedex, France|1182.58.33019 H?pital de l'H?tel Dieu, Lyon cedex 2, France|1182.58.33031 H?pital edouard Herriot, Lyon cedex 3, France|1182.58.33009 H?pital de la Conception, Marseille cedex 5, France|1182.58.33023 H?pital Sainte Marguerite, Marseille cedex 9, France|1182.58.33030 H?pital Saint Eloi, Montpellier, France|1182.58.33032 H?pital Emile Muller, Mulhouse cedex 1, France|1182.58.33008 H?pital H?tel Dieu, Nantes cedex 1, France|1182.58.33003 H?pital de l'Archet, Nice cedex 3, France|1182.58.33013 H?pital Saint Louis, Paris cedex 10, France|1182.58.33014 H?pital Cochin, Paris cedex 14, France|1182.58.33007 H?pital Georges Pompidou, Paris cedex 15, France|1182.58.33005 H?pital Bichat, Paris cedex 18, France|1182.58.33017 H?pital Bichat Claude Bernard, Paris cedex 18, France|1182.58.33033 H?pital Tenon, Paris cedex 20, France|1182.58.33018 H?pital Saint Antoine, Paris, France|1182.58.33024 H?pital Necker, Paris, France|1182.58.33035 H?pital des Ab?mes, Pointe A Pitre, France|1182.58.33012 H?pital Robert Debré, Reims cedex, France|1182.58.33026 H?pital Ponchaillou, Rennes cedex 9, France|1182.58.33015 H?pital Civil, Strasbourg cedex, France|1182.58.33025 H?pital Foch, Suresnes cedex, France|1182.58.33021 H?pital Chalucet, Toulon cedex, France|1182.58.33002 H?pital Purpan, Toulouse cedex 9, France|1182.58.33016, Tourcoing, France|1182.58.33010 H?pital Brabois, Vandoeuvre Les Nancy, France|1182.58.33011 H?pital Paul Brousse, Villejuif cedex, France|1182.58.3001, Athens, Greece|1182.58.44029 Our Lady For Sick Children, Dublin 12, Ireland|1182.58.44016 St James Hospital, Dept of Genito Urinary Medicine, Dublin, Ireland|1182.58.3903 Università di Brescia, Brescia, Italy|1182.58.3904 Ospedali Riuniti di Foggia, Foggia, Italy|1182.58.3901 Ospedale Luigi Sacco, Milano, Italy|1182.58.3902 Ospedale L. Sacco, Milano, Italy|1182.58.3907 Presidio Ospedaliero di Rimini, Rimini, Italy|1182.58.3905 Presidio Dalmati, S. Angelo Lodigiano (lo), Italy|1182.58.3906 Ospedale Infantile Regina Margherita, Torino, Italy|1182.58.3908 Centro Medicina Preventiva, Verona, Italy|1182.58.35102 Hospital Condes Castro Guimar?es, Cascais, Portugal|1182.58.27095 Boehringer Ingelheim Investigational Site, Cape Town, South Africa|1182.58.27098 Boehringer Ingelheim Investigational Site, Cape Town, South Africa|1182.58.27099 Boehringer Ingelheim Investigational Site, Cape Town, South Africa|1182.58.27096 Boehringer Ingelheim Investigational Site, Durban, South Africa|1182.58.27097 Boehringer Ingelheim Investigational Site, Westville, Durban, South Africa|1182.58.4101 Boehringer Ingelheim Investigational Site, Basel, Switzerland|1182.58.4103 Boehringer Ingelheim Investigational Site, Bern, Switzerland|1182.58.4104 Boehringer Ingelheim Investigational Site, Genève, Switzerland|1182.58.4107 Boehringer Ingelheim Investigational Site, Genève, Switzerland|1182.58.4102 Boehringer Ingelheim Investigational Site, Zürich, Switzerland|1182.58.4105 Boehringer Ingelheim Investigational Site, Zürich, Switzerland|1182.58.44020 Beckenham Hospital, Beckenham, United Kingdom|1182.58.44004 Boehringer Ingelheim Investigational Site, Brighton, United Kingdom|1182.58.44002 Boehringer Ingelheim Investigational Site, Cardiff, United Kingdom|1182.58.44025 Boehringer Ingelheim Investigational Site, Chertsey, United Kingdom|1182.58.44019 Boehringer Ingelheim Investigational Site, Chichester, United Kingdom|1182.58.44009 Boehringer Ingelheim Investigational Site, Edinburgh, United Kingdom|1182.58.44023 Boehringer Ingelheim Investigational Site, Harrow, United Kingdom|1182.58.44024 Boehringer Ingelheim Investigational Site, Leeds, United Kingdom|1182.58.44003 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44005 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44008 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44010 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44014 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44017 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44018 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44026 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44027 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44028 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44031 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.58.44011 Boehringer Ingelheim Investigational Site, Peterborough, United Kingdom|1182.58.44022 Boehringer Ingelheim Investigational Site, Woolwich, United Kingdom|1182.58.44030 Boehringer Ingelheim Investigational Site, Woolwich, United Kingdom Less << | |
NCT02251795 | Healthy | Phase 1 | Completed | - | - |
NCT00530920 | - | Completed | - | - | |
NCT00344123 | HIV Infections | Phase 1 | Completed | - | United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less << |
NCT02253875 | Healthy | Phase 1 | Completed | - | - |
NCT00607958 | HIV Infections | Phase 4 | Completed | - | Spain ... More >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Less << |
NCT00486330 | - | Completed | - | - | |
NCT00146328 | HIV Infections | PHASE2|PHASE3 | COMPLETED | - | 1182.17.39 MDS Pharma Services... More >>, Phoenix, Arizona, United States|1182.17.75 Boehringer Ingelheim Investigational Site, Phoenix, Arizona, United States|1182.17.89 Boehringer Ingelheim Investigational Site, Berkeley, California, United States|1182.17.60 Boehringer Ingelheim Investigational Site, Fountain Valley, California, United States|1182.17.106 Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|1182.17.15 Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|1182.17.40 Tower ID Medical, Los Angeles, California, United States|1182.17.46 Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|1182.17.47 University of Southern California, Los Angeles, California, United States|1182.17.73 Boehringer Ingelheim Investigational Site, Los Angeles, California, United States|1182.17.114 Boehringer Ingelheim Investigational Site, San Diego, California, United States|1182.17.128 Boehringer Ingelheim Investigational Site, San Diego, California, United States|1182.17.37 Boehringer Ingelheim Investigational Site, San Francisco, California, United States|1182.17.58 Boehringer Ingelheim Investigational Site, San Francisco, California, United States|1182.17.96 Boehringer Ingelheim Investigational Site, San Francisco, California, United States|1182.17.87 Boehringer Ingelheim Investigational Site, Norwalk, Connecticut, United States|1182.17.112 Boehringer Ingelheim Investigational Site, Washington, District of Columbia, United States|1182.17.43 Boehringer Ingelheim Investigational Site, Washington, District of Columbia, United States|1182.17.65 Boehringer Ingelheim Investigational Site, Washington, District of Columbia, United States|1182.17.126 Boehringer Ingelheim Investigational Site, Fort Lauderdale, Florida, United States|1182.17.8 Boehringer Ingelheim Investigational Site, Fort Myers, Florida, United States|1182.17.131 Boehringer Ingelheim Investigational Site, Miami, Florida, United States|1182.17.22 Boehringer Ingelheim Investigational Site, Miami, Florida, United States|1182.17.64 Boehringer Ingelheim Investigational Site, Orlando, Florida, United States|1182.17.129 Boehringer Ingelheim Investigational Site, Sarasota, Florida, United States|1182.17.51 Boehringer Ingelheim Investigational Site, South Miami, Florida, United States|1182.17.125 Boehringer Ingelheim Investigational Site, Tampa, Florida, United States|1182.17.132 Boehringer Ingelheim Investigational Site, Tampa, Florida, United States|1182.17.76 Boehringer Ingelheim Investigational Site, Tampa, Florida, United States|1182.17.52 Boehringer Ingelheim Investigational Site, Vero Beach, Florida, United States|1182.17.77 Boehringer Ingelheim Investigational Site, Atlanta, Georgia, United States|1182.17.69 Boehringer Ingelheim Investigational Site, Macon, Georgia, United States|1182.17.136 Boehringer Ingelheim Investigational Site, Chicago, Illinois, United States|1182.17.70 Boehringer Ingelheim Investigational Site, Chicago, Illinois, United States|1182.17.36 Boehringer Ingelheim Investigational Site, Evanston, Illinois, United States|1182.17.1 Boehringer Ingelheim Investigational Site, Indianapolis, Indiana, United States|1182.17.32 University of Kansas School of Medicine - Wichita, Wichita, Kansas, United States|1182.17.102 Boehringer Ingelheim Investigational Site, Lexington, Kentucky, United States|1182.17.21 Boehringer Ingelheim Investigational Site, Louisville, Kentucky, United States|1182.17.30 Boehringer Ingelheim Investigational Site, Portland, Maine, United States|1182.17.67 Boehringer Ingelheim Investigational Site, Baltimore, Maryland, United States|1182.17.86 Boehringer Ingelheim Investigational Site, Bethesda, Maryland, United States|1182.17.111 Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States|1182.17.63 Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States|1182.17.74 Boehringer Ingelheim Investigational Site, Springfield, Massachusetts, United States|1182.17.4 Boehringer Ingelheim Investigational Site, Ann Arbor, Michigan, United States|1182.17.115 Boehringer Ingelheim Investigational Site, Detroit, Michigan, United States|1182.17.6 Boehringer Ingelheim Investigational Site, Detroit, Michigan, United States|1182.17.62 Boehringer Ingelheim Investigational Site, Kansas City, Missouri, United States|1182.17.59 Boehringer Ingelheim Investigational Site, Las Vegas, Nevada, United States|1182.17.118 Early Intervention Program (EIP) Clinic, Camden, New Jersey, United States|1182.17.93 Boehringer Ingelheim Investigational Site, East Orange, New Jersey, United States|1182.17.24 Hackensack University Medical Center, Hackensack, New Jersey, United States|1182.17.34 ID Care, Inc., Hillsborough, New Jersey, United States|1182.17.50 Boehringer Ingelheim Investigational Site, Santa Fe, New Mexico, United States|1182.17.79 Boehringer Ingelheim Investigational Site, Albany, New York, United States|1182.17.103 Boehringer Ingelheim Investigational Site, Mount Vernon, New York, United States|1182.17.105 Pollari Medical Group, New York, New York, United States|1182.17.130 Boehringer Ingelheim Investigational Site, New York, New York, United States|1182.17.3 Division of Infectious Diseases, New York, New York, United States|1182.17.42 Beth Israel Medical Center, New York, New York, United States|1182.17.5 Boehringer Ingelheim Investigational Site, New York, New York, United States|1182.17.7 Boehringer Ingelheim Investigational Site, New York, New York, United States|1182.17.94 Boehringer Ingelheim Investigational Site, New York, New York, United States|1182.17.135 Boehringer Ingelheim Investigational Site, Rochester, New York, United States|1182.17.31 Boehringer Ingelheim Investigational Site, Stony Brook, New York, United States|1182.17.53 Boehringer Ingelheim Investigational Site, Durham, North Carolina, United States|1182.17.54 Boehringer Ingelheim Investigational Site, Huntersville, North Carolina, United States|1182.17.134 Summa Health System, Akron, Ohio, United States|1182.17.95 Boehringer Ingelheim Investigational Site, Cincinnati, Ohio, United States|1182.17.26 Boehringer Ingelheim Investigational Site, Columbus, Ohio, United States|1182.17.9 Boehringer Ingelheim Investigational Site, Oklahoma City, Oklahoma, United States|1182.17.110 Boehringer Ingelheim Investigational Site, Philadelphia, Pennsylvania, United States|1182.17.99 Boehringer Ingelheim Investigational Site, Philadelphia, Pennsylvania, United States|1182.17.23 Boehringer Ingelheim Investigational Site, Columbia, South Carolina, United States|1182.17.11 Boehringer Ingelheim Investigational Site, Memphis, Tennessee, United States|1182.17.18 Vanderbilt AIDS Clinical Trials Center, Nashville, Tennessee, United States|1182.17.116 Boehringer Ingelheim Investigational Site, Dallas, Texas, United States|1182.17.142 Boehringer Ingelheim Investigational Site, Dallas, Texas, United States|1182.17.16 Nelson-Tebedo Clinic, Dallas, Texas, United States|1182.17.122 Boehringer Ingelheim Investigational Site, Houston, Texas, United States|1182.17.68 Boehringer Ingelheim Investigational Site, Houston, Texas, United States|1182.17.97 Boehringer Ingelheim Investigational Site, San Antonio, Texas, United States|1182.17.10 Boehringer Ingelheim Investigational Site, Annandale, Virginia, United States|1182.17.92 Boehringer Ingelheim Investigational Site, Tacoma, Washington, United States|1182.17.100 Boehringer Ingelheim Investigational Site, Milwaukee, Wisconsin, United States|1182.17.5401 Fundacion Huesped, Capital Federal, Argentina|1182.17.5402 Funcei, Capital Federal, Argentina|1182.17.5403 consultorio externo "PETS", Capital Federal, Argentina|1182.17.5404 Infectología, Capital Federal, Argentina|1182.17.5405 Dpto. de Enfermedades infecciosas (Pabellón 22), Capital Federal, Argentina|1182.17.5406 Pabellón de Clínicas 2° Piso, Capital Federal, Argentina|1182.17.401 St. Vincent's Hospital, Darlinghurst, New South Wales, Australia|1182.17.402 Taylor Square Private Clinic, Darlinghurst, New South Wales, Australia|1182.17.405 AIDS Research Initiative, DarlingHurst, New South Wales, Australia|1182.17.407 Holdsworth House General Practice, Darlinghurst, New South Wales, Australia|1182.17.408 407 Doctors Pty Ltd., Darlinghurst, New South Wales, Australia|1182.17.403 Albion Street Clinic, Surry Hills, New South Wales, Australia|1182.17.404 Alfred Hospital, Melbourne, Victoria, Australia|1182.17.4301 Boehringer Ingelheim Investigational Site, Wien, Austria|1182.17.3209 Instituut Tropische Geneeskunde, Antwerpen, Belgium|1182.17.3201 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1182.17.3202 Boehringer Ingelheim Investigational Site, Bruxelles, Belgium|1182.17.3207 Boehringer Ingelheim Investigational Site, Gent, Belgium|1182.17.3210 Centre Hospitalier de Luxembourg, Luxembourg, Belgium|1182.17.5511 Universidade Federal da Bahia, Canela - Salvador - BA, Brazil|1182.17.5508 I.I. Emilio Ribas, Cerqueira César, S?o Paulo - SP, Brazil|1182.17.5509 (Unidade de Testes Terapêuticos), Cidade Nova - Rio de Janeiro - RJ, Brazil|1182.17.5502 Farmácia do Instituto de Pesquisa Evandro Chagas, Manguinhos - Rio de Janeiro - RJ, Brazil|1182.17.5505 Instituto A-Z de Pesquisa e Ensino da PUC, Mercês - Curitiba - PR, Brazil|1182.17.5507 Hospital Geral de Nova Igua?u - Ministério da Saúde, Nova Igua?u - Rio de Janeiro - RJ, Brazil|1182.17.5501 Hospital Dia, Sacoma - S?o Paulo - SP, Brazil|1182.17.5503 Instituto de Infectologia Emílio Ribas, S?o Paulo - SP, Brazil|1182.17.5504 Enfermaria de MI, S?o Paulo - SP, Brazil|1182.17.5510 Casa de AIDS, S?o Paulo, SP, Brazil|1182.17.5506 Centro de Referência e Treinamento - DST/AIDS, Vila Mariana, Sao Paulo - SP, Brazil|1182.17.902 Downtown Infectious Diseases Clinic, Vancouver, British Columbia, Canada|1182.17.913 McMaster University Medical Centre, Hamilton, Ontario, Canada|1182.17.901 Division of Infectious Diseases, Ottawa, Ontario, Canada|1182.17.905 Canadian Immunodeficiency Research Collaborative Inc., Toronto, Ontario, Canada|1182.17.906 Infectious Diseases & HIV - St. Michael's Hospital, Toronto, Ontario, Canada|1182.17.907 University Health Network - Toronto General Hospital, Toronto, Ontario, Canada|1182.17.910 Sunnybrook & Women's College Health Science Centre, Toronto, Ontario, Canada|1182.17.914 Montreal General Hospital - McGill University Health Centre, Monteal, Quebec, Canada|1182.17.903 Montreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada|1182.17.904 Clinique Medicale Du Quartier Latin, Montreal, Quebec, Canada|1182.17.915 Clinique medicale l'Actuel, Montreal, Quebec, Canada|1182.17.4505 Boehringer Ingelheim Investigational Site, Aarhus N, Denmark|1182.17.4501 Boehringer Ingelheim Investigational Site, Copenhagen ?, Denmark|1182.17.4502 Boehringer Ingelheim Investigational Site, Hvidovre, Denmark|1182.17.4504 Boehringer Ingelheim Investigational Site, Odense, Denmark|1182.17.33011 H?pital Pellegrin, Bordeaux cedex, France|1182.17.33019 H?pital Saint André, Bordeaux cedex, France|1182.17.33020 H?pital C?te de Nacre, Caen cedex 5, France|1182.17.33007 H?pital Antoine Beclere, Clamart, France|1182.17.33008 H?pital de l'H?tel Dieu, Lyon cedex 2, France|1182.17.33023 H?pital Edouard Herriot, Lyon cedex 3, France|1182.17.33012 H?pital de la Conception, Marseille cedex 5, France|1182.17.33013 H?pital Sainte Marguerite, Marseille cedex 9, France|1182.17.00336 H?pital H?tel Dieu, Nantes cedex 1, France|1182.17.33010 H?pital de l'Archet, Nice cedex 3, France|1182.17.33024 Groupe Hospitalier Cochin, Paris cedex 14, France|1182.17.33022 H?pital Européen Georges Pompidou, Paris cedex 15, France|1182.17.00335 H?pital Bichat Claude Bernard, Paris cedex 18, France|1182.17.00331 H?pital Tenon, Paris cedex 20, France|1182.17.00333 H?pital Saint Louis, Paris, France|1182.17.00334 H?pital de la Pitié Salpêtrière, Paris, France|1182.17.33014 H?pital Saint Antoine, Paris, France|1182.17.33018 H?pital de Pontchaillou, Rennes cedex 9, France|1182.17.33016 H?pital Civil, Strasbourg cedex, France|1182.17.00332 H?pital du Chalucet, Toulon, France|1182.17.33017 H?pital Brabois Adultes, Vandoeuvre les Nancy, France|1182.17.33021 H?pital Paul Brousse, Villejuif cedex, France|1182.17.4911 Arzt für Innere Medizin, Aachen, Germany|1182.17.4901 Epimed GmbH c/o, Berlin, Germany|1182.17.4902 Charite, Campus Virchow-Klinikum, Berlin, Germany|1182.17.4918 Rheinische Friedrich-Wilhelm-Universit?t, Bonn, Germany|1182.17.4906 ID-Ambulanz Klinikum Dortmund, Dortmund, Germany|1182.17.4912 Universit?tsklinikum Düsseldorf, Düsseldorf, Germany|1182.17.4914 Arzt für Innere Medizin, Düsseldorf, Germany|1182.17.4908 Universit?tskliniken Erlangen, Erlangen, Germany|1182.17.4904 Universit?tsklinikum Essen, Essen, Germany|1182.17.4924 Klinikum der J. W.-Goethe-Universit?t, Frankfurt/Main, Germany|1182.17.4930 Universit?tsklinikum Freiburg, Freiburg/Breisgau, Germany|1182.17.4928 Facharzt für Innere Medizin/Rheumatologie, Freiburg, Germany|1182.17.4916 Medizinisches Versorgungszentrum Hamburg, Hamburg, Germany|1182.17.4929 Universit?tsklinikum Eppendorf, Hamburg, Germany|1182.17.4931 IPM Study Center GmbH, Hamburg, Germany|1182.17.4920 Abteilung Klinische Immunologie, Hannover, Germany|1182.17.4909 Universit?tsklinikum Heidelberg, Heidelberg, Germany|1182.17.4905 Universit?tsklinik K?ln, K?ln, Germany|1182.17.4926 Internist, K?ln, Germany|1182.17.4923 Facharzt für Innere Medizin,, Mannheim, Germany|1182.17.4907 Medizinische Poliklinik, München, Germany|1182.17.4910 MUC Research GmbH, München, Germany|1182.17.4915 Klinium Natruper Holz, Osnabrück, Germany|1182.17.4921 Arzt für Allgemeinmedizin, Stuttgart, Germany|1182.17.3001 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3002 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3003 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3004 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3007 Boehringer Ingelheim Investigational Site, Athens, Greece|1182.17.3010 Boehringer Ingelheim Investigational Site, Patras, Greece|1182.17.3009 Boehringer Ingelheim Investigational Site, Thessaloniki, Greece|1182.17.0409 Ospedale Santa Maria Annunziata, Antella (fi), Italy|1182.17.0413 Ospedale di Circolo di Busto, Busto Arsizio (va), Italy|1182.17.0384 Azienda Ospedaliera Arcispedale S. Anna, Ferrara, Italy|1182.17.0397 Ospedale San Martino, Genova, Italy|1182.17.0412 S.C. Malattie Infettive, Genova, Italy|1182.17.0411 Presidio Ospedaliero "A. Manzoni", Lecco, Italy|1182.17.0389 Reparto Malattie Infettive, Macerata, Italy|1182.17.0393 Fondazione Centro S. Raffaele del Monte Tabor, Milano, Italy|1182.17.0386 Policlinico Universitario, Modena, Italy|1182.17.0388 Ospedale A. Cotugno, Napoli, Italy|1182.17.0385 IRCCS Policlinico San Matteo, Pavia, Italy|1182.17.0394 IRCCS Policlinico San Matteo, Pavia, Italy|1182.17.0395 Azienda Policlinico Umberto I, Roma, Italy|1182.17.0419 I Cattedra Malattie Infettive, Roma, Italy|1182.17.0387 Ospedale Amedeo di Savoia, Torino, Italy|1182.17.0398 Ospedale Amedeo di Savoia, Torino, Italy|1182.17.0415 U.O.A. Malattie Infettive B, Torino, Italy|1182.17.5201 Centro Médico La Raza IMSS, Col. La Raza, Mexico, Mexico|1182.17.5203 Hospital Civil Nuevo de Guadalajara, Guadalajara, Mexico|1182.17.5206 Centro Medico San Vicente, Monterrey, N.l., Mexico, Mexico|1182.17.3101 Boehringer Ingelheim Investigational Site, Amsterdam, Netherlands|1182.17.3108 Boehringer Ingelheim Investigational Site, Groningen, Netherlands|1182.17.3105 Boehringer Ingelheim Investigational Site, Nijmegen, Netherlands|1182.17.202 Boehringer Ingelheim Investigational Site, Rotterdam, Netherlands|1182.17.3502 Hospital Condes Castro Guimar?es, Cascais, Portugal|1182.17.705 Hospital Germans Trias i Pujol, Badalona, Spain|1182.17.701 Hospital Clínico y Provincial de Barcelona, Barcelona, Spain|1182.17.703 Hospital 12 de Octubre, Madrid, Spain|1182.17.704 Hospital Ramón y Cajal., Madrid, Spain|1182.17.710 Hospital Gregorio Maranon, Madrid, Spain|1182.17.712 Hospital Clínico San Carlos, Madrid, Spain|1182.17.717 Hospital Clínico Universitario Vírgen de la Victoria, Malaga, Spain|1182.17.713 Hospital Universitario Vírgen del Rocío, Sevilla, Spain|1182.17.714 Hospital General Universitario de Valencia, Valencia, Spain|1182.17.720 Hospital La Fe, Valencia, Spain|1182.17.718 Complejo Hospitalario Xeral - Cíes, Vigo, Spain|1182.17.4101 DIM / Abteilung für Infektiologie, Basel, Switzerland|1182.17.4104 Département de médicine interne Div. Des maladies infectieus, Genève, Switzerland|1182.17.4103 DIM / Abteilung für Infektiologie, St. Gallen, Switzerland|1182.17.4102 Departement für Innere Medizin, Zürich, Switzerland|1182.17.4405 Boehringer Ingelheim Investigational Site, Brighton, United Kingdom|1182.17.4411 Boehringer Ingelheim Investigational Site, Liverpool, United Kingdom|1182.17.4404 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4406 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4408 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4409 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4414 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4418 Boehringer Ingelheim Investigational Site, London, United Kingdom|1182.17.4407, Portsmouth, United Kingdom Less << |
NCT02253797 | Healthy | Phase 1 | Completed | - | - |
NCT02257021 | Healthy | Phase 1 | Completed | - | - |
NCT02244190 | Healthy | Phase 1 | Completed | - | - |
NCT02226991 | Healthy | Phase 1 | Completed | - | - |
NCT00486330 | HIV Infections | Not Applicable | Completed | - | United States, Connecticut ... More >> Yale University School of Medicine AIDS Program New Haven, Connecticut, United States, 06510 Less << |
NCT02251158 | Healthy | Phase 1 | Completed | - | - |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.66mL 0.33mL 0.17mL |
8.30mL 1.66mL 0.83mL |
16.59mL 3.32mL 1.66mL |